|
Atomistry » Zinc » PDB 3s2n-3sbj » 3s45 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Zinc » PDB 3s2n-3sbj » 3s45 » |
Zinc in PDB 3s45: Wild-Type Hiv-2 Protease with Antiviral Drug AmprenavirEnzymatic activity of Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir
All present enzymatic activity of Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir:
3.4.23.47; Protein crystallography data
The structure of Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir, PDB code: 3s45
was solved by
Y.-F.Tie,
Y.-F.Wang,
I.T.Weber,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 3s45:
The structure of Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir
(pdb code 3s45). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 7 binding sites of Zinc where determined in the Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir, PDB code: 3s45: Jump to Zinc binding site number: 1; 2; 3; 4; 5; 6; 7; Zinc binding site 1 out of 7 in 3s45Go back to Zinc Binding Sites List in 3s45
Zinc binding site 1 out
of 7 in the Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir
Mono view Stereo pair view
Zinc binding site 2 out of 7 in 3s45Go back to Zinc Binding Sites List in 3s45
Zinc binding site 2 out
of 7 in the Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir
Mono view Stereo pair view
Zinc binding site 3 out of 7 in 3s45Go back to Zinc Binding Sites List in 3s45
Zinc binding site 3 out
of 7 in the Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir
Mono view Stereo pair view
Zinc binding site 4 out of 7 in 3s45Go back to Zinc Binding Sites List in 3s45
Zinc binding site 4 out
of 7 in the Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir
Mono view Stereo pair view
Zinc binding site 5 out of 7 in 3s45Go back to Zinc Binding Sites List in 3s45
Zinc binding site 5 out
of 7 in the Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir
Mono view Stereo pair view
Zinc binding site 6 out of 7 in 3s45Go back to Zinc Binding Sites List in 3s45
Zinc binding site 6 out
of 7 in the Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir
Mono view Stereo pair view
Zinc binding site 7 out of 7 in 3s45Go back to Zinc Binding Sites List in 3s45
Zinc binding site 7 out
of 7 in the Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir
Mono view Stereo pair view
Reference:
Y.Tie,
Y.F.Wang,
P.I.Boross,
T.Y.Chiu,
A.K.Ghosh,
J.Tozser,
J.M.Louis,
R.W.Harrison,
I.T.Weber.
Critical Differences in Hiv-1 and Hiv-2 Protease Specificity For Clinical Inhibitors. Protein Sci. V. 21 339 2012.
Page generated: Sat Oct 26 15:33:01 2024
ISSN: ISSN 0961-8368 PubMed: 22238126 DOI: 10.1002/PRO.2019 |
Last articlesZn in 9JYWZn in 9IR4 Zn in 9IR3 Zn in 9GMX Zn in 9GMW Zn in 9JEJ Zn in 9ERF Zn in 9ERE Zn in 9EGV Zn in 9EGW |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |